Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04353921 · ClinicalTrials.gov registry record
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
A clinical trial, sponsored by Usona Institute.
- Terminated
- Registry status
- 26
- Enrollment target
NCT04353921 is a clinical trial that was terminated before completion, run by Usona Institute. The registered enrollment target is 26 participants.
The verdict
NCT04353921 was terminated before completion, sponsored by Usona Institute.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This is a Phase 2 double-blind, long-term observational follow-up study of participants from Study PSIL201. Participants providing informed consent were enrolled into this study and completed web surveys and telephone interviews conducted by one central site at the following time intervals: months 3 and 6 (± 7 days for each assessment) and months 10 and 12 (± 14 days for each assessment).
Interventions
- OTHER No intervention will be administered as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-06-30 |
| Est. Completion | 2022-10-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04353921
The ClinicalTrials.gov registry entry for NCT04353921 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Usona Institute, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention will be administered as part of this study. is the first listed.
NCT04353921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04353921 about?
NCT04353921 is a clinical study titled "PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder". This is a Phase 2 double-blind, long-term observational follow-up study of participants from Study PSIL201. Participants providing informed consent were enrolled into this study and completed web surveys and telephone interviews conducted by one central site at the following time intervals: months 3...
What is the current status of trial NCT04353921?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2020-06-30. Estimated completion is 2022-10-18.
What interventions are being tested in trial NCT04353921?
The interventions under investigation include: No intervention will be administered as part of this study. (OTHER).
Who is sponsoring clinical trial NCT04353921?
This trial is sponsored by Usona Institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.